CD123 TARGETED IMMUNOTHERAPIES
The present disclosure provides improved CD123 targeting polypeptides and compositions for adoptive T cell therapies for treating, preventing, or ameliorating at least one symptom of a cancer, infectious disease, autoimmune disease, inflammatory disease, and immunodeficiency, or condition associated...
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
12.11.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!